Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix

Gynecologic Oncology

Volumn 65, Issue 1, 1997, Pages 23-29

  Uchiyama, Michiko ^a   Iwasaka, Tsuyoshi ^a   Matsuo, Norihito ^a   Hachisuga, Toru ^a   Mori, Mitsuru ^a   Sugimori, Hajime ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 0031127068     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4613     Document Type: Article

References (29)

1. 1. Lorincz AT, Temple GF, Kurman RJ, Jenson AB, Lancaster WD: Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst 79:671-677, 1987
2. 2. Leminen A, Paavonen J, Vesterinen E, Wahlstrom T, Rantala I, Lehtinen M: Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Am J Clin Pathol 95:647-652, 1991
3. 3. Duggan MA, Benoit JL, McGregor SE, Nation JG, Inoue M, Stuart GC: The human papillomavirus status of 114 endocervical adenocarcinoma cases by dot blot hybridization. Hum Pathol 24:121-125, 1993
4. 4. Matsuo N, Iwasaka T, Hayashi Y, Hara K, Mvula M, Sugimori H: Polymerase chain reaction analysis of human papillomavirus in adenocarcinoma and adenosquamous carcinoma of uterine cervix. Int J Gynecol Cancer 3:363-368, 1993
5. 5. Hollstein M, Sidramsky D, Vogelstem B, Harris CC: p53 mutations in human cancers. Science 253:49-53, 1991
6. 6. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM: The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell 63:1129-1136, 1990
7. 7. Scheffner M, Munger K, Byrne JC, Howley PM: The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88:5523-5527, 1991
8. 8. Crook T, Wrede D, Vousden KH: p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6:873-875, 1991
9. 9. Iwasaka T, Oh-uchida M, Matsuo N, Yokoyama M, Fukuda K, Hara K, Fukuyama K, Hori K, Sugimori H: Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines. Gynecol Oncol 48:104-109, 1993
10. 10. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H, Iwamoto A: Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 82:524-531, 1991
11. 11. Iwai K, Hachisuga T, Iwasaka T, Sugimori H: Immunohistochemical detection of p53 overexpression in formalin-fixed, paraffin-embedded sections of endometrial carcinoma. J Obstet Gynecol 21:593-600, 1995
12. 12. zur Hausen H: Papillomaviruses as Carcinomaviruses, in Klein G (ed): Advances in Viral Oncology. New York, Raven Press, 1989, pp 1-26
13. 13. Young FI, Ward LM, Brown LJR: Absence of human papilloma virus in cervical adenocarcinoma determined by in situ hybridization. J Clin Pathol 44:340-341, 1991
14. 14. Griffin NR, Dockey D, Lewis FA, Wells M: Demonstration of low frequency of human papillomavirus DNA in cervical adenocarcinoma and adenocarcinoma in situ by the polymerase chain reaction and in situ hybridization. Int J Gynecol Pathol 10:36-43, 1991
15. 15. Yamakawa Y, Forslund O, Teshima H, Hasumi K, Kitagawa T, Hansson BG: Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction. Gynecol Oncol 53:190-195, 1994
16. 16. Duggan MA, McGregor SE, Benoit JL, Inoue M, Nation JG, Stuart GC: The human papillomavirus status of invasive cervical adenocarcinoma: A clinicopathological and outcome analysis. Hum Pathol 26:319-325, 1995
17. 17. Crook T, Wrede D, Tidy J, Mason WP, Evans DJ, Vousden KH: Clonal p53 mutation in primary cervical cancer: Association with human papilloma virus-negative tumors. Lancet 339:1070-1073, 1992
18. 18. Paquette RL, Lee YY, Wilczynski SP, Karmaker A, Kizaki M, Miller CW, Koeffler HP: Mutation of p53 and human papillomavirus infection in cervical carcinoma. Cancer 72:1272-1280, 1993
19. 19. Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T: Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 52:5323-5328, 1992
20. 20. Busby-Earle RMC, Steel CM, Williams ARW, Cohen B, Bird CC: p53 mutations in cervical carcinogenesis - Low frequency and lack of correlation with human papillomavirus status. Br J Cancer 69:732-737, 1994
21. 21. Mittal KR, Lin O, Chan W, Goswami S, Demopoulos RI: Cervical squamous dysplasia and carcinomas with immunodetectable p53 frequently contain HPV. Gynecol Oncol 58:289-294, 1995
22. 22. Cardillo MR, Stamp GWH, Pignatelli MN, Lalani EN: Immunohistochemical analysis of p53 oncoprotein and proliferating cell nuclear antigen (PCNA) in the cervix uteri. Eur J Gynaec Oncol 15:484-490, 1993
23. 23. Bosari S, Roncalli M, Viale G, Bossi P, Coggi G: p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix. J Pathol 169:425-430, 1993
24. 24. King SA, Adas AA, LiVolsi VA, Takahashi H, Behbakht K, McGovern P, Benjamin I, Rubin SC, Boyd J: Expression and mutation analysis of the p53 gene in uterine papillary serous carcinoma. Cancer 75:2700-2705, 1995
25. 25. Jeffers MD, Farquharson MA, Richmond JA, McNicol AM: p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus. J Pathol 177:65-70, 1995
26. 26. Burns JS, Blaydes JP, Wright PA, Lemoine L, Bond JA, Williams ED, Wynford-Thomas D: Step-wise transformation of primary thyroid epithelial cells by a mutant H-ras oncogene: An in vitro model of tumour progression. Mol Carcinogen 6:129-139, 1992
27. 27. Wynford-Thomas D: p53 in tumour pathology: Can we trust immunocytochemistry? J Pathol 166:329-330, 1992
28. 28. Riou G, Favre M, Jannel D, Bourhis J, Le Doussal V, Orth G: Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 335:1171-1174, 1990
29. 29. Higgins GD, Davy M, Roder D, Uzelin DM, Phillips GE, Burrel CJ: Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 338:910-913, 1991